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Abstract--Several 2,5-bis(1-aziridinyl)-1,4-benzoquinones (BABQs) can be activated to alkylating 
species by reduction of the quinone moiety. On the other hand, cytotoxicity of these compounds can 
be induced by redox cycling. A series of BABQs and their methylated analogues (BMABQs) with 
different substituents at the 3- and 6-position was synthesized in order to investigate the influence of 
the substituents on the reduction of the quinone moiety and on the generation of superoxide anion 
radicals with rat liver microsomes. Superoxide anion production (SAP) ranged from 3.7 -+ 0.1 to 742 -+ 74 
nmoles/min/mg protein with quinone concentrations of 10 nmoles/ml. NADPH-oxidation was measured 
under the same conditions and it correlated well (r = 0.88, P < 0.001) with SAP. It ranged from 1.4 --- 0.2 
to 494-+ 60nmoles/min/mg protein. SAP for 22 B(M)ABQs showed a good correlation with the 
summated electronic substituent constant O'para.total (F = 0.86, P < 0.001). It can be concluded that 
superoxide anion production by 22 B(M)ABQs in rat liver microsomes can be predicted from structural 
features of the compounds. 
The concept of bioreductive activation has been 
developed since 1972 to explain the antitumor 
activity of quinone-containing antibiotics [1]. This 
concept has been used to obtain drugs with selectivity 
for hypoxic cells [2, 3]. Hypoxic cells exist in solid 
tumors in regions of poor vascularization where a 
reductive nvironment might prevail. Since oxygen- 
deficient cells have a limited sensitivity to radio- 
therapy and most chemotherapy, the development 
of drugs that are active to hypoxic cells is very 
important [4]. Well known examples of biore- 
ductively activated cytostatic drugs are the quinone 
compounds Adriamycin ®and mitomycin C [2, 5]. 
At present, two classes of bioreductively activated 
drugs are in clinical use: the quinone containing 
alkylating agents in chemotherapy and the hypoxic 
cell sensitizers (e.g. nitroimidazoles) in radiotherapy 
[4]. The clinical use of these compounds often is 
limited by dose-dependent side effects. These effects 
probably are caused by reactive oxygen inter- 
mediates that are formed by redox cycling of the 
quinone moiety [6]. Based on AZQ~: and related 
compounds evaluated by Driscoll et al. [7] we syn- 
thesized a series of 2,5-bis (1-aziridinyl)-l,4-benzo- 
quinones and methylated analogues (Table 1, Fig. 
1). These compounds contain two active parts: the 
quinone moiety and the alkylating aziridinyl groups. 
Reduction of the quinone moiety to the hydro- 
quinone facilitates protonation and opening of the 
* Author to whom correspondence should be addressed. 
$ Abbreviations used: AZQ, diaziquone; BABQ, 2,5- 
bis(1-aziridinyl)-l,4-benzoquinone; BMABQ, 2,5-bis(2- 
methyl-l-aziridinyl)-l,4-benzoquinone; CQ, carboquone; 
SOD, superoxide dismutase; SAP, superoxide anion pro- 
duction; SCC, succinoylated cytochrome c; and Tre, Tren- 
imon. 
aziridine ring [8]. After one-electron reduction and 
the formation of a semiquinone reactive oxygen 
species can be formed by redox cycling of the quinone 
moiety [10]. Semiquinone formation has been shown 
to occur for AZQ too [11]. For several quinones it 
is assumed that superoxide anions formed by redox 
cycling play an important role in the acute cyto- 
toxicity [12]. In the development of quinone-con- 
taining cytostatic drugs it is important o predict 
these acute effects by redox cycling in an early stage. 
In this study we investigated the ability of a series 
of 2,5-bis(1-aziridinyl)-l,4-benzoquinones for r dox 
cycling with rat liver microsomes. The electro- 
chemical parameters and the antitumor activity of 
these compounds bearing different substituents at 
the 3- and 6-position were studied by Driebergen et 
al. [8]. The results of measurements of redox cycling 
are compared with several structural parameters of 
the substituents. 
MATERIALS AND METHODS 
Compounds. The compounds that are used in this 
study are designated by TW-numbers and presented 
in Table 1. 
BABQ (TW 13), BMABQ (TW 29), 3,6-dichloro- 
BABQ (TW 14), 3,6-dichloro-BMABQ (TW 18), 
3,6-dibromo-BABQ (TW 16) and 3,6-dibromo- 
BMABQ (TW 17) were prepared as described pre- 
viously [13]. 3,6-Difluoro-BABQ (TW 19) 3,6- 
difluoro-BMABQ (TW 20) and 3-(1-aziridinyl)-6- 
fluoro-BABQ (TW 26) were prepared as described 
by Chou et al. [14]. 3-Methyl-6-bromo-BABQ (TW 
22), 3-ethyl-6-bromo-BABQ (TW 25) and 3-[(2- 
carbamoyloxy)-l-ethyl]-6-bromo-BABQ (TW 50), 
3 - [2-(carbamoyloxy)-l-ethyl] - 6- methyl - BMABQ 
(TW 87) were synthesized as described by Nakao et 
3753 
3754 B. PRINS et al. 
Table 1. Aziridinylbenzoquinones with their substituents and structural features [9] 
Substituents Log k' (HPLC E~/2 
TW nr. R1 R2 capacity factor) O'para.total (mV) 
13 H H 0.44 -0.50 - 105 
29-Me H H 0.15 -0.54 -115 
14 C1 CI 0.35 -0.04 -113 
18-Me CI CI 0.88 -0.08 - 125 
16 Br Br 0.48 -0.04 - -  
17-Me Br Br 1.00 -0.08 - -  
19 F F -0.15 -0.38 -87 
20-Me F F 0.44 -0.42 -93 
22 Br CH 3 0.28 -0.44 - 185 
53-Me Br CH 3 0.76 -0.48 - 194 
25 Br C2H5 0.51 -0.42 -210 
50 Br C2H4OCONH2 0.19 -0.36 -201 
81 CI CH 3 0.20 -0.44 - 197 
Tre Az H -0.45 -0.75 - 171 
26 Az F -0.31 -0.69 -171 
AZQ NHCO2CzH s (2 ×) -0.48 -0.80 - 149 
73-Me NHCO2C2H5 (2×) 0.04 -0.84 -145 
32 CH 3 C2H 5 0.29 -0.82 -227 
40 CH3 C2H40H -0.42 -0.83 -209 
39 CH3 C2H4OCONH2 -0.43 -0.76 -213 
87-Me CH 3 C2HaOCONH2 0.19 -0.80 -235 
CQ CH 3 CHOCH3CH2OCONH2 0.44 -0.74 - 182 
- not measured. 
Log k' = HPLC capacity factor (rc-ro)/ro for 50% methanol/0.5 M Na-phosphatc pH 6.5. 
ap.ra.tota~ = summated electronic substituent (Hammett) constant. 
El~ 2 = electrochemically determined half wave potential. 
Az = aziridinyl group Me = methylaziridinyl group 
CH2 HC---CH3 
- -N  - -N  
\ \ 
CH2 CH 2 
O 
R2~N~ -R3 
0 
Fig. 1. Chemical structure of aziridinylbenzoquinones. R1 
and R 2 are different substituents and R3 is a hydrogen or a 
methyl group. 
al. [15]. 3-Methyl -6-bromo-BMABQ (TW 53) and 
3-methyl-6-chloro-BABQ (TW 81) were prepared 
by treatment of the corresponding 2-halo-5-methyl- 
1,4-benzoquinone with 1-(2-methylaziridine) anal- 
ogously as described by Nakao et al. [16]. 3-Ethyl-6- 
methyl -BABQ (TW 32), 3-(2-hydroxyethyl)-6- 
methyl -BABQ (TW 40) and its corresponding car- 
bamate ester (TW 39) were prepared as described 
by Nakao et al. [16]. 3,6-Bis(ethoxycarbonylamino)- 
BMABQ (TW 73) was synthesized according to 
Khan and Driscoil [17]. AZQ [2,5-bis(1-aziridinyl)- 
3,6 - bis(ethoxycarbonylamino) - 1,4-benzoquinone] 
was a gift from the Drug Synthesis and Chemistry 
Branch (National Cancer Institute, Maryland) and 
CQ [2,5-bis-(1-aziridinyl)-3-{2-(carbamoyloxy)-l- 
(methoxyethyl)}-6-methyl-l,4-benzoquinone] was a 
gift from the Chemical Research Laboratories (San- 
kyo Co., Ltd, Tokyo, Japan). 3-(1-Aziridinyl)- 
BABQ (Trenimon) was a gift from Bayer AG 
(Pharma Research Center, Wuppertal, F .R.G.) .  
All 22 TW-compounds were freshly dissolved 
(5 raM) in dimethylsulfoxide (Merck, scintillation 
grade). Cytochrome c (horse heart, type III) was 
from Boehringer-Mannheim; NADPH (type X) and 
SOD (EC 1.15.1.1) were purchased from Sigma 
Chemical Co., trinitrobenzenesulphonic acid was 
from Serva and succinic anhydride was from Janssen 
Chimica. 
Methods .  Liver microsomes were prepared from 
male Wistar rats (Hsd /Cpb:WU,  Harlan-CPB, 
Zeist, the Netherlands) in 100mM Na-phosphate 
containing 0.1 mM EDTA pH 7.4. Protein was deter- 
mined according to Lowry et al. [18]. Partial suc- 
cinoylation of cytochrome c was performed as 
described by Kuthan et al. [19]. The initial velocity 
of the SOD-inhibitable reduction of SCC (50 #M) 
was used for quantitative detection of superoxide 
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Fig. 2. Microsomal superoxide anion (SA) production 
(nmoles succinoylated cytochrome c reduction/min/mg 
protein) vs NADPH oxidation (nmoles/min/g protein) for 
22 B(M)ABQs (10/tM) under carbogen gassing at 37 °. 
Each point represents he mean of 3 separate measurements 
for one compound. The numbers refer to the compounds 
mentioned in Table 1. SAP ranges from 3.7 to 742 nmoles/ 
min/mg and NADPH oxidation ranges from 1.4 to 494 
nmoles/min/mg. 
anion radicals. The reduction of SCC at 37 ° under 
95% 02/5% CO2 was monitored at 550nm and 
e550= 19.5mM-1 was used for calculations. 
NADPH-oxidation was performed under the same 
conditions and monitored at 340 nm. The reactions 
were carried out in Milli-Q (Millipore) purified water 
containing 100 mM Na-phosphate + 0.1 mM EDTA 
pH 7.4, 10 #M B(M)ABQ in dimethylsulfoxide (1% 
v/v), SOD (10IU/ml, if relevant), 0.04mg/ml 
microsomal protein and were started with NADPH 
(400 #M). Basal rates of microsomal NADPH-oxi- 
dation and SCC reduction were subtracted from 
quinone-mediated measurements. Statistical analysis 
was performed using a multivariate least-squares 
program from SYSTAT [20]. Physicochemical prop- 
erties (lipophilicity determined as the HPLC capacity 
ratio (k') and the electrochemically determined half 
wave reduction potential El/2) were taken from 
Driebergen [9] (see Table 1). Substituent constants 
for electronic (Opar.) and steric (MR) effects were 
from Hansch et al. [21] or were calculated by 
Driebergen [9]. 
RESULTS 
Without added microsomes no direct reaction was 
observed between the B(M)ABQs and NADPH or 
between the B(M)ABQs and SCC. In the presence of 
NADPH, B(M)ABQs and microsomes the reduction 
of SCC was inhibited more than 95% by SOD (10 IU /  
ml). Superoxide anion production (SAP) was deter- 
mined for 22 B(M)ABQs at quinone concentrations 
of 10 #M. Under nitrogen gassing the reduction of 
SCC was below 1.0nmole/min/mg for all com- 
pounds. Under carbogen gassing SAP ranged from 
3.7 -+ 0.1 to 724 -+ 74 nmoles/min/mg protein (Fig. 
2). For 4 B(M)ABQs bearing two bromo- or chloro- 
substituents (TW 14,18,16,17) the maximal SAP was 
Table 2. Microsomal superoxide anion production (SAP) 
and NADPH-oxidation of 22 aziridinylbenzoquinones 
under carbogen gassing at 37 °. Mean -+ SE 
SAP NADPH-oxidation 
TW n. (nmoles/min/mg) (nmoles/min/mg) 
13 123 -+ 19 204 -+ 24 
29-Me 56 -+ 9 83 -+ 8 
14 545 -+ 81 164 -+ 20 
18-Me 445 _+ 67 67 -+ 9 
16 742 _+ 74 494 -+ 60 
17-Me 635 -+ 86 200 ___ 25 
19 53 -+ 7 7.7 -+ 1.7 
20-Me 59 -+ 8 2.9 -+ 1.3 
22 279 -+ 39 121 -+ 23 
53-Me 317 --- 31 81 -+ 8 
25 260 --- 30 62 -+ 8 
50 304 -+ 26 29 -+ 6 
81 260 +- 29 74 - 7 
Tre 21 --_ 3 28 -+ 4 
26 52 -+ 3 31 - 5 
AZQ 36 - 4 7.6 -+ 1.2 
73-Me 18 -+ 2 7.5 _+ 1.0 
32 7.4 _+ 1 1.7 -+ 0.2 
40 8.9 -+ 1 5.7 -+ 0.6 
39 10.4 -+ 2 3.2 -+ 0.3 
87-Me 3.6 -+ 0.2 1.4 -+ 0.2 
CQ 3.7 + 0.1 1.7 -+ 0.2 
See Table 1 for substituents. 
already reached at 10/~M. BABQs with one or two 
fluoro-substituents (TW 19,20,26) showed a much 
lower SAP at this concentration. For BABQs with 
one bromo- or chloro-substituent (TW 
22,25,50,53,81) a higher SAP was found at 10gM 
than with the unsubstituted BABQ (TW 13). The 
lowest SAP was found for compounds bearing one 
methyl and one ethyl derivative function (TW 
32,39,40, CQ). When the SAP of 7 BMABQs was 
compared with that of the corresponding non- 
methylated BABQs there were 4 that showed no 
significant difference (Table 2). In contrast TW 29, 
TW 73 and TW 87 showed a significantly lower SAP 
at 10#M when compared with the corresponding 
non-methylated compounds TW 13, AZQ and TW 
39. 
Microsomal NADPH-oxidation was measured for 
the 22 compounds; at 10/~M it ranged from 1.4 -+ 0.2 
to 494---60 nmoles/min/mg (Fig. 2, Table 2). At 
quinone concentrations of 10gM microsomal 
NADPH-oxidation correlated well with superoxide 
anion production (r = 0.88, P < 0.001) for the 22 
quinones. For most compounds SAP was between 
1.0 and 5.0 times NADPH-oxidation (nmoles/ 
min/mg). 
In view of the good agreement of quinone- 
mediated microsomal SAP with NADPH-oxidation 
we only used SAP for correlations with several 
experimentally determined physicochemical par- 
ameters (log k', E1/2) and with electronic substituent 
constants (Opara,total) describing both the inductive 
field and the resonance component of the sub- 
stituents [9]. SAP for 22 B(M)ABQs showed a stat- 
istically significant correlation with log k' (r = 0.67, 
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Fig. 3. Microsomal superoxide anion (SA) production 
(nmoles succinoylated cytochrome c reduction/min/mg 
protein) vs the electronic substituent constant O'para,total for 
22 B(M)ABQs (10#M) under carbogen gassing at 37 °. 
Each point represents the mean of 3 separate measurements 
for one compound. The numbers refer to the compounds 
mentioned inTable 1. SAP ranges from 3.7 to 742 nmoles/ 
min/mg. 
P = 0.001) but the correlation with the electro- 
chemically determined half wave potential E1/2 was 
not statistically significant (r = 0.31, P > 0.05). How- 
ever, the correlation of SAP with E1/2 was con- 
siderably improved when compounds with bromo- 
or chloro-substituents were omitted (N = 13, r = 
0.72, P < 0.001). SAP for 22 B(M)ABQs showed 
a good correlation with the electronic substituent 
constant Opara summated for all substituents: r = 0.88, 
P < 0.001 (Fig. 3). Inclusion of lipophilicity (log k') 
or steric (MR) parameters in a multiple linear 
regression analysis did not improve this correlation. 
DISCUSSION 
Reduction of the quinone moiety is known to 
initiate the bioactivation of BABQs like AZQ and 
CQ to alkylating agents [11]. Therefore, a series of 
BABQs and corresponding BMABQs was syn- 
thesized to investigate the influence of electron-with- 
drawing and electron-donating substituents on the 
reduction of the quinone moiety and on the biological 
activation of these compounds. Their capacity for 
redox cycling was measured in a microsomal system 
by the oxidation of NADPH and by the production 
of superoxide anions (SAP) as measured by the 
reduction of SCC. The selective inhibition of SCC- 
reduction in the presence of SOD or a nitrogen 
atmosphere demonstrate hat in the presence of 95% 
02 superoxide anions or other reactive oxygen 
species are formed. The good correlation of quinone- 
mediated SCC-reduction with microsomal NADPH- 
oxidation--both exceeding the quinone concen- 
trat ion- impl ies that under the chosen conditions 
(95% 02) both can be used as parameters for redox 
cycling of B(M)ABQs. The one-electron reduction 
by NADPH-cytochrome P-450 reductase may play 
an important role in the reductive activation of 
B(M)ABQs. This is suggested by the findings of 
Powis and Appel [22]. With a series of 1,4-benzo- 
quinones they found a linear relationship beween 
quinone-dependent superoxide formation by 
NADPH-cytochrome P-450 reductase and by the 
hepatic microsomal fraction in the presence of 
NADPH. 
We used experimentally determined physico- 
chemical parameters (log k' and El~2) and electronic 
substituent constants (Hammett constant Opara ) [9] to 
correlate the capacity of B(M)ABQs for redox cyc- 
ling (SAP, NADPH-oxidation) with structural par- 
ameters. The correlation of SAP and Ell2 was poor, 
probably because Ell 2 represents a combined 2-elec- 
tron transfer and protonation by which the hydro- 
quinone is formed. SAP and Ell 2 were better 
correlated for compounds without bromo- or chloro- 
substituents. This can be explained by assuming that 
these substituents can hinder the protonation or the 
second electron-transfer [9]. Correlation of SAP with 
log k' was significant, but it should be noted that 
for the 22 compounds used log k' and Opara,total re 
intercorrelated (r = 0.61, P < 0.003). However, 
when the influence of methyl substitution on the 
aziridinyl functions is considered, no (positive) effect 
of 2 additional methyl groups on SAP was found 
despite a considerable positive (+0.55) effect on the 
log k'-value. This is in agreement with the obser- 
vation of Driebergen et al. [8] that methylation of 
the aziridines has a minor effect on electrochemical 
reduction of the quinone ring as measured by the 
half wave potential. 
Concluding, it can be said that the ability of 
B(M)ABQs for redox cycling, as measured by 
superoxide anion production and NADPH-oxidation 
in a microsomal system, can be reasonably predicted 
from structural features using the electronic sub- 
stituent constant only. Therefore, introduction of 
electron-donating substituents in B(M)ABQs dim- 
inishes their redox cycling in a microsomal system. 
Thus, if the production of reactive oxygen radicals 
is a good predictive parameter for acute cytotoxicity 
of bioreductively activated quinones the introduction 
of such substituents could be an effective way of 
diminishing acute toxic effects. 
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